These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 28386324)
21. MicroRNA-182 promotes proliferation and metastasis by targeting FOXF2 in triple-negative breast cancer. Zhang X; Ma G; Liu J; Zhang Y Oncol Lett; 2017 Oct; 14(4):4805-4811. PubMed ID: 29085483 [TBL] [Abstract][Full Text] [Related]
22. miR-1207-5p regulates the sensitivity of triple-negative breast cancer cells to Taxol treatment via the suppression of LZTS1 expression. Hou X; Niu Z; Liu L; Guo Q; Li H; Yang X; Zhang X Oncol Lett; 2019 Jan; 17(1):990-998. PubMed ID: 30655858 [TBL] [Abstract][Full Text] [Related]
23. MicroRNA-137 Inhibits Cancer Progression by Targeting Del-1 in Triple-Negative Breast Cancer Cells. Lee SJ; Jeong JH; Kang SH; Kang J; Kim EA; Lee J; Jung JH; Park HY; Chae YS Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817673 [TBL] [Abstract][Full Text] [Related]
24. miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer. Li J; Lai Y; Ma J; Liu Y; Bi J; Zhang L; Chen L; Yao C; Lv W; Chang G; Wang S; Ouyang M; Wang W BMC Cancer; 2017 Nov; 17(1):745. PubMed ID: 29126392 [TBL] [Abstract][Full Text] [Related]
25. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression. Guo GC; Wang JX; Han ML; Zhang LP; Li L Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302 [TBL] [Abstract][Full Text] [Related]
26. MicroRNA-206 inhibits metastasis of triple-negative breast cancer by targeting transmembrane 4 L6 family member 1. Fan C; Liu N; Zheng D; Du J; Wang K Cancer Manag Res; 2019; 11():6755-6764. PubMed ID: 31413629 [No Abstract] [Full Text] [Related]
27. The long noncoding RNA sONE represses triple-negative breast cancer aggressiveness through inducing the expression of miR-34a, miR-15a, miR-16, and let-7a. Youness RA; Hafez HM; Khallaf E; Assal RA; Abdel Motaal A; Gad MZ J Cell Physiol; 2019 Nov; 234(11):20286-20297. PubMed ID: 30968427 [TBL] [Abstract][Full Text] [Related]
28. Is miR-144 an effective inhibitor of PTEN mRNA: a controversy in breast cancer. Kia V; Sharif Beigli M; Hosseini V; Koochaki A; Paryan M; Mohammadi-Yeganeh S In Vitro Cell Dev Biol Anim; 2018 Oct; 54(9):621-628. PubMed ID: 30132256 [TBL] [Abstract][Full Text] [Related]
29. MicroRNA-454 may function as an oncogene via targeting AKT in triple negative breast cancer. Li Q; Liu J; Meng X; Pang R; Li J J Biol Res (Thessalon); 2017 Dec; 24():10. PubMed ID: 28795052 [TBL] [Abstract][Full Text] [Related]
30. miR-365 inhibits cell invasion and migration of triple negative breast cancer through ADAM10. Liu F; Zhuang L; Wu R; Li D J BUON; 2019; 24(5):1905-1912. PubMed ID: 31786854 [TBL] [Abstract][Full Text] [Related]
31. MicroRNA-211, a direct negative regulator of CDC25B expression, inhibits triple-negative breast cancer cells' growth and migration. Song GQ; Zhao Y Tumour Biol; 2015 Jul; 36(7):5001-9. PubMed ID: 25680404 [TBL] [Abstract][Full Text] [Related]
32. miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer. Chen J; Shin VY; Siu MT; Ho JC; Cheuk I; Kwong A BMC Cancer; 2016 Nov; 16(1):887. PubMed ID: 27842518 [TBL] [Abstract][Full Text] [Related]
33. Caprin-1 is a novel microRNA-223 target for regulating the proliferation and invasion of human breast cancer cells. Gong B; Hu H; Chen J; Cao S; Yu J; Xue J; Chen F; Cai Y; He H; Zhang L Biomed Pharmacother; 2013 Sep; 67(7):629-36. PubMed ID: 23953883 [TBL] [Abstract][Full Text] [Related]
34. MiR-145 promotes TNF-α-induced apoptosis by facilitating the formation of RIP1-FADDcaspase-8 complex in triple-negative breast cancer. Zheng M; Wu Z; Wu A; Huang Z; He N; Xie X Tumour Biol; 2016 Jul; 37(7):8599-607. PubMed ID: 26733177 [TBL] [Abstract][Full Text] [Related]
35. MicroRNA-301b promotes cell proliferation and apoptosis resistance in triple-negative breast cancer by targeting CYLD. Song H; Li D; Wu T; Xie D; Hua K; Hu J; Deng X; Ji C; Deng Y; Fang L BMB Rep; 2018 Nov; 51(11):602-607. PubMed ID: 30269739 [TBL] [Abstract][Full Text] [Related]
36. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer. Song H; Wu T; Xie D; Li D; Hua K; Hu J; Fang L Cell Physiol Biochem; 2018; 48(5):1968-1982. PubMed ID: 30092563 [TBL] [Abstract][Full Text] [Related]
37. [Effect of miRNA-135b on proliferation, invasion and migration of triple-negative breast cancer by targeting APC]. Xin H; Jiang D; Lü Z; Sun S; Kong J; Li F Zhonghua Yi Xue Za Zhi; 2015 Aug; 95(30):2474-7. PubMed ID: 26711213 [TBL] [Abstract][Full Text] [Related]
38. Loss of miR-873 contributes to gemcitabine resistance in triple-negative breast cancer via targeting ZEB1. Wang G; Dong Y; Liu H; Ji N; Cao J; Liu A; Tang X; Ren Y Oncol Lett; 2019 Oct; 18(4):3837-3844. PubMed ID: 31579087 [TBL] [Abstract][Full Text] [Related]
39. MiR-137 Suppresses Triple-Negative Breast Cancer Stemness and Tumorigenesis by Perturbing BCL11A-DNMT1 Interaction. Chen F; Luo N; Hu Y; Li X; Zhang K Cell Physiol Biochem; 2018; 47(5):2147-2158. PubMed ID: 29975921 [TBL] [Abstract][Full Text] [Related]
40. Overexpression of microRNA-620 facilitates the resistance of triple negative breast cancer cells to gemcitabine treatment by targeting DCTD. Wu C; Zhao A; Tan T; Wang Y; Shen Z Exp Ther Med; 2019 Jul; 18(1):550-558. PubMed ID: 31258693 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]